XML 117 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements Of Stockholders' Equity (USD $)
In Thousands, except Share data, unless otherwise specified
Common Stock [Member]
Additional Paid-in Capital [Member]
Deferred Stock Units [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Income [Member]
Treasury Stock [Member]
Total IDEXX Laboratories, Inc.Stockholders' Equity [Member]
Noncontrolling Interest [Member]
Total
Balance, value at Dec. 31, 2010 $ 9,797 $ 641,645 $ 4,433 $ 965,540 $ 13,467 $ (1,060,647) $ 574,235 $ 46 $ 574,281
Balance, shares at Dec. 31, 2010 97,968                
Comprehensive Income:                  
Net income       161,786     161,786 (32) 161,754
Other comprehensive (loss) income, net of tax         1,976   1,976   1,976
Comprehensive income             163,762 (32) 163,730
Repurchases of common stock           (259,729) (259,729)   (259,729)
Common stock issued under stock plans, including excess tax benefit, shares 1,261                
Common stock issued under stock plans, including excess tax benefit, value 126 45,747         45,873   45,873
Issuance of deferred stock units     91       91   91
Vesting of deferred stock units   (164) 164            
Share-based compensation cost recognized   15,347         15,347   15,347
Balance, value at Dec. 31, 2011 9,923 702,575 4,688 1,127,326 15,443 (1,320,376) 539,579 14 539,593
Balance, shares at Dec. 31, 2011 99,229                
Comprehensive Income:                  
Net income       178,267     178,267 20 178,287
Other comprehensive (loss) income, net of tax         511   511   511
Comprehensive income             178,778 20 178,798
Repurchases of common stock           (136,808) (136,808)   (136,808)
Common stock issued under stock plans, including excess tax benefit, shares 931                
Common stock issued under stock plans, including excess tax benefit, value 93 38,943 (365)       38,671   38,671
Issuance of deferred stock units     142       142   142
Vesting of deferred stock units   (165) 165            
Share-based compensation cost recognized   15,861         15,861   15,861
Balance, value at Dec. 31, 2012 10,016 757,214 4,630 1,305,593 15,954 (1,457,184) 636,223 34 636,257
Balance, shares at Dec. 31, 2012 100,160               100,160,000
Comprehensive Income:                  
Net income       187,800     187,800 (6) 187,794
Other comprehensive (loss) income, net of tax         (2,332)   (2,332)   (2,332)
Comprehensive income             185,468 (6) 185,462
Repurchases of common stock           (372,194) (372,194)   (372,194)
Common stock issued under stock plans, including excess tax benefit, shares 1,028                
Common stock issued under stock plans, including excess tax benefit, value 103 51,861 (38)       51,926   51,926
Issuance of deferred stock units     189       189   189
Vesting of deferred stock units   (259) 259            
Share-based compensation cost recognized   16,504 70       16,574   16,574
Balance, value at Dec. 31, 2013 $ 10,119 $ 825,320 $ 5,110 $ 1,493,393 $ 13,622 $ (1,829,378) $ 518,186 $ 28 $ 518,214
Balance, shares at Dec. 31, 2013 101,188               101,188,000